Scholarlink

Objective <p>Glycemic variability (GV) and systolic blood pressure variability (SBPV) have been reported to be associated with all-cause mortality. However, it remains unclear whether the combination of these parameters further stratifies mortality risk in septic patients admitted to the intensive care unit (ICU). The aim of this study was to investigate the combined association of GV and SBPV with mortality in patients with sepsis.</p> Methods <p>The study utilized data from MIMIC-IV database. Patients with sepsis were stratified into four groups. The endpoint indicators of this study include ICU mortality, in-hospital mortality, 30-day mortality, 90-day mortality, 180-day mortality, and 1-year mortality. Kaplan-Meier method was used to estimate the survival curves. The risks of ICU mortality, in-hospital mortality, and mortality at 30 days, 90 days, 180 days, and 1 year were assessed using Cox regression analyses. The study also performed subgroup analysis to evaluate the robustness of the findings. In addition, we evaluated the predictive value of GV and SBPV for mortality by calculating the Harrell C-index, IDI and NRI for each parameter separately and in combination.</p> Results <p>Among 15,454 patients with sepsis, 1,576 patients died in ICU, and 5,189 patients died 1-year follow-up. High GV and high SBPV were associated with an increased risk of mortality. Patients with high GV and high SBPV have higher risk of ICU mortality (HR 1.56, 95% CI 1.32–1.85), in-hospital mortality (HR 1.46, 95% CI 1.26–1.69), 30-day mortality (HR 1.42, 95% CI 1.24–1.63), 90-day mortality (HR 1.32, 95% CI 1.17–1.49), 180-day mortality (HR 1.31, 95% CI 1.17–1.47), and 1-year mortality (HR 1.29, 95% CI 1.16–1.44) than those with low GV and low SBPV. Across all endpoints, the combination of GV and SBPV significantly improved predictive accuracy compared to GV or SBPV alone. Furthermore, the increased risk of mortality associated with high GV and high SBPV was more significant in patients with age &lt; 60 (<i>P</i> for interaction &lt; 0.001).</p> Conclusion <p>GV and SBPV were each independently associated with an increased risk of mortality in septic patients admitted to the ICU, and their combination demonstrated an additive association with mortality risk in this population. Monitoring and potentially managing these hemodynamic parameters may be important for risk stratification in severe sepsis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The additive effect of glycemic variability and systolic blood pressure variability on mortality in patients with sepsis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月16日

查看全文
  • Hong-Jin Zhang,
  • Wen-Liang Shuai,
  • Meng-Bo Wu,
  • Wen-Cheng Yan,
  • Yang Fu,
  • Hong-Zhou Zhang

摘要

Objective

Glycemic variability (GV) and systolic blood pressure variability (SBPV) have been reported to be associated with all-cause mortality. However, it remains unclear whether the combination of these parameters further stratifies mortality risk in septic patients admitted to the intensive care unit (ICU). The aim of this study was to investigate the combined association of GV and SBPV with mortality in patients with sepsis.

Methods

The study utilized data from MIMIC-IV database. Patients with sepsis were stratified into four groups. The endpoint indicators of this study include ICU mortality, in-hospital mortality, 30-day mortality, 90-day mortality, 180-day mortality, and 1-year mortality. Kaplan-Meier method was used to estimate the survival curves. The risks of ICU mortality, in-hospital mortality, and mortality at 30 days, 90 days, 180 days, and 1 year were assessed using Cox regression analyses. The study also performed subgroup analysis to evaluate the robustness of the findings. In addition, we evaluated the predictive value of GV and SBPV for mortality by calculating the Harrell C-index, IDI and NRI for each parameter separately and in combination.

Results

Among 15,454 patients with sepsis, 1,576 patients died in ICU, and 5,189 patients died 1-year follow-up. High GV and high SBPV were associated with an increased risk of mortality. Patients with high GV and high SBPV have higher risk of ICU mortality (HR 1.56, 95% CI 1.32–1.85), in-hospital mortality (HR 1.46, 95% CI 1.26–1.69), 30-day mortality (HR 1.42, 95% CI 1.24–1.63), 90-day mortality (HR 1.32, 95% CI 1.17–1.49), 180-day mortality (HR 1.31, 95% CI 1.17–1.47), and 1-year mortality (HR 1.29, 95% CI 1.16–1.44) than those with low GV and low SBPV. Across all endpoints, the combination of GV and SBPV significantly improved predictive accuracy compared to GV or SBPV alone. Furthermore, the increased risk of mortality associated with high GV and high SBPV was more significant in patients with age < 60 (P for interaction < 0.001).

Conclusion

GV and SBPV were each independently associated with an increased risk of mortality in septic patients admitted to the ICU, and their combination demonstrated an additive association with mortality risk in this population. Monitoring and potentially managing these hemodynamic parameters may be important for risk stratification in severe sepsis.